Cargando…
Use, Safety Assessment, and Implementation of Two Point-of-Care Tests for COVID-19 Testing
OBJECTIVES: The Abbot ID NOW COVID-19 assay and Quidel Sofia 2 SARS Antigen FIA are point-of-care assays that offer rapid testing for severe acute respiratory syndrome coronavirus 2 viral RNA and nucleocapsid protein, respectively. Given the utility of these devices in the field, we investigated the...
Autores principales: | Hahn, Megan, Olsen, Aaron, Stokes, Kindra, Fowler, Randal C, Gu, Rui, Semple-Lytch, Shellanne, DeVito, Andrea, Kurpiel, Philip, Hughes, Scott, Rakeman, Jennifer L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336596/ https://www.ncbi.nlm.nih.gov/pubmed/34302455 http://dx.doi.org/10.1093/ajcp/aqab081 |
Ejemplares similares
-
Point‐of‐care testing in primary care: A systematic review on implementation aspects addressed in test evaluations
por: Lingervelder, Deon, et al.
Publicado: (2019) -
Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study
por: García-Fiñana, Marta, et al.
Publicado: (2021) -
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test
por: Mostafa, Heba H., et al.
Publicado: (2021) -
SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States
por: Leelawong, Mindy, et al.
Publicado: (2021) -
Implementing quality assurance for laboratory-based and point-of-care HIV testing in Nigeria
por: Abubakar, Ado, et al.
Publicado: (2016)